出典:Wiktionary
出典:『Wiktionary』 (2015/07/09 07:58 UTC 版)
regorafenib (uncountable)
出典:Wikipedia
出典:『Wikipedia』 (2011/06/30 23:11 UTC 版)
Regorafenib (BAY 73-4506) is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. It is currently being studied as a potential treatment option in multiple tumor types.